Neofysis Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Neofysis Biotech
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Palakkal Binaf, Aseema Faisal, Faisal Parambathkandi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299KA2020PTC138071
- Company No.
138071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Neofysis Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palakkal Siraj  | Director | 16-Jun-2022 | Current |
| Palakkal Binaf | Director | 16-Jun-2022 | Current |
| Aseema Faisal | Director | 03-Sep-2020 | Current |
| Faisal Parambathkandi | Director | 03-Sep-2020 | Current |
Financial Performance of Neofysis Biotech.
Enhance accessibility to Neofysis Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Neofysis Biotech?
Unlock access to Neofysis Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
R G B Broadcasting Equipments Private LimitedActive 15 years 1 monthPalakkal Binaf and Palakkal Siraj are mutual person
Grandeland Realtors Private LimitedActive 4 years 12 daysPalakkal Binaf and Palakkal Siraj are mutual person
- Aujuz Realtors And Properties Private LimitedActive 7 years 2 months
Palakkal Binaf and Palakkal Siraj are mutual person
- Aujuz Infrastructure Developers Private LimitedActive 5 years 9 months
Palakkal Binaf and Palakkal Siraj are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neofysis Biotech?
Neofysis Biotech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neofysis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neofysis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
